Transcatheter aortic valve implantation (TAVI) is the primary therapeutic option for severe aortic stenosis that are inoperable or have high surgical risk.
Scope of the Report:
This report focuses on the Cerebral Thrombectomy Systems in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Diffusion-weighted MRI studies demonstrates that after TAVI some silent embolic cerebral infarcts are present that lead to consecutive mental deterioration. Cerebral embolic protection (CEP) devices is used to reduce the risk of stroke, neurocognitive decline and dementia caused by brain emboli associated with cardiovascular procedures.
The worldwide market for Cerebral Thrombectomy Systems is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2018.
Market Segment by Manufacturers, this report covers:
Terumo
ohnson and Johnson
Stryker
Vascular Solutions
Boston Scientific
Medtronic
Teleflex
Penumbra
The Spectranetics Corporation
AngioDynamics
Market Segment by Regions, regional analysis covers:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers:
Clarets Sentinel System
Keystone Hearts Triguard Device
Embrella Embolic Deflector
Market Segment by Applications, can be divided into:
Hospital
Clinic
There are 15 Chapters to deeply display the global Cerebral Thrombectomy Systems market.
Chapter 1, to describe Cerebral Thrombectomy Systems Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Cerebral Thrombectomy Systems, with sales, revenue, and price of Cerebral Thrombectomy Systems, in 2016 and 2018;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2018;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Cerebral Thrombectomy Systems, for each region, from 2013 to 2019;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2019;
Chapter 12, Cerebral Thrombectomy Systems market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024;
Chapter 13, 14 and 15, to describe Cerebral Thrombectomy Systems sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source